TBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TrueBlue Inc (TBI) does not present a strong buy opportunity for a beginner long-term investor at this moment. While there are positive insider buying trends and slight pre-market price gains, the technical indicators, financial performance, and lack of strong trading signals suggest that waiting for clearer positive catalysts or improved financial metrics would be prudent.
The technical indicators for TBI are bearish. The MACD is below zero and negatively contracting, RSI is neutral at 41.836, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below its pivot level of 4.102, with key support at 3.579 and resistance at 4.626.
Insiders are buying significantly, with a 1035.89% increase in buying activity over the last month. Revenue increased by 8.35% YoY in Q4 2025.
The MACD and moving averages indicate bearish trends.
In Q4 2025, revenue increased to $418.18M (up 8.35% YoY), net income improved to -$31.54M (up 169.42% YoY), and EPS improved to -1.05 (up 162.50% YoY). However, the gross margin dropped to 20.06%, down 19.79% YoY.
Baird lowered the price target to $5.50 from $7 while maintaining an Outperform rating. This suggests cautious optimism but reflects reduced expectations for the stock's performance.
